Inventor · disambiguated record
Liat Dassa
Also filed as: DASSA LIAT
19 granted patents·23 pending applications·84 citations·filing 2008–2025
94Inventor score
Top patents by PatentIndex Score
42 records- 0195US12312404B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2023·Granted May 27, 2025·1 cites·16 claims
- 0294US11623955B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2020·Granted Apr 11, 2023·3 cites·33 claims
- 0394US9714289B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Jul 25, 2017·14 cites·20 claims
- 0493US10124061B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2017·Granted Nov 13, 2018·9 cites·20 claims
- 0592US10751415B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2017·Granted Aug 25, 2020·6 cites·22 claims
- 0692US10213505B2Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2018·Granted Feb 26, 2019·6 cites·2 claims
- 0791US11220542B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Jan 11, 2022·3 cites·42 claims
- 0890US10227408B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2016·Granted Mar 12, 2019·6 cites·20 claims
- 0985US8415455B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsLEVINE ZURIT·Filed 2008·Granted Apr 9, 2013·9 cites·14 claims
- 1084US9617336B2C10RF32 antibodies, and uses thereof for treatment of cancerCOMPUGEN LTD·Filed 2013·Granted Apr 11, 2017·14 cites·23 claims
- 1184US9107862B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Aug 18, 2015·5 cites·9 claims
- 1284US2025333503A1Anti-pvrig antibodies and methods of useCOMPUGEN LTD·Filed 2025·Application pending·0 cites
- 1383US11701424B2Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereofCOMPUGEN LTD·Filed 2020·Granted Jul 18, 2023·1 cites·30 claims
- 1481US9375466B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Jun 28, 2016·3 cites·4 claims
- 1581US2024025973A1Pvrig polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 1679US2024139318A1Anti-tigit antibodies, anti-pvrig antibodies and combinations thereofCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 1778US10550173B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2016·Granted Feb 4, 2020·2 cites·10 claims
- 1875US11795220B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2020·Granted Oct 24, 2023·0 cites·24 claims
- 1974US9555087B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2014·Granted Jan 31, 2017·1 cites·27 claims
- 2073US10098934B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Oct 16, 2018·1 cites·9 claims
- 2172US2024287174A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 2270US11795209B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2020·Granted Oct 24, 2023·0 cites·15 claims
- 2369US2011311450A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsLEVINE ZURIT·Filed 2009·Application pending·0 cites
- 2468US10351625B2Anti-PVRIG antibodies and methods of useCOMPUGEN LTD·Filed 2018·Granted Jul 16, 2019·0 cites·34 claims
- 2563US2018298109A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2018·Application pending·0 cites
- 2660US2024400679A1Anti-ror1 antibodies and uses thereofIMMUNORIZON LTD·Filed 2022·Application pending·0 cites
- 2759US2024228658A1Anti-5t4 antibodies and uses thereofIMMUNORIZON LTD·Filed 2022·Application pending·0 cites
- 2859US2020002416A1C10rf32 antibodies, and uses thereof for treatment of cancerCOMPUGEN LTD·Filed 2019·Application pending·0 cites
- 2958US2017037141A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 3057US2011052501A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsDASSA LIAT·Filed 2009·Application pending·0 cites
- 3157US2024228626A1Anti-nkg2d antibodies and uses thereofIMMUNORIZON LTD·Filed 2022·Application pending·0 cites
- 3256US2016068606A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2015·Application pending·0 cites
- 3355US2017107284A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 3454US2016272707A1Vstm5 antibodies, and uses thereof for treatment of cancer, infectious diseases and immune related diseasesCOMPUGEN LTD·Filed 2014·Application pending·0 cites
- 3554US2023312753A1Precursor tri-specific antibody constructs and methods of use thereofIMMUNORIZON LTD·Filed 2021·Application pending·0 cites
- 3649US2013315819A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Application pending·0 cites
- 3748US2018305451A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 3845US2017233473A1C10rf32 antibodies, and uses thereof for treatment of cancerCOJOCARU GADY S·Filed 2017·Application pending·0 cites
- 3945US2020270343A1Anti-vsig10 antibodies and methods of useCOMPUGEN LTD·Filed 2018·Application pending·0 cites
- 4041US2010184839A1Allelic polymorphism associated with diabetesVAKNIN AVISHAY·Filed 2008·Application pending·0 cites
- 4140US2014294765A1Lsr antibodies, and uses thereof for treatment of cancerCOMPUGEN LTD·Filed 2013·Application pending·0 cites
- 4239US2016347814A1Vstm5 polypeptides and uses thereof as a drug for treatment of cancer, infectious diseases and immune related diseasesCOMPUGEN LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Liat Dassa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →